Autophagy initiation machinery (AIM)

The autophagy initiation machinery is a sophisticated multi-protein assembly responsible for triggering the de novo formation of the autophagosome, a double-membrane vesicle that sequesters cytoplasmic components for lysosomal degradation (PMID: 31061444). At its core, this machinery primarily consists of the ULK1 (Unc-51 like autophagy activating kinase 1) complex—comprising ULK1, ATG13, RB1CC1, and ATG101—and the Class III Phosphoinositide 3-kinase (PI3K) complex I, which includes VPS34, Beclin-1, ATG14, and VPS15 (PMID: 28803722). These complexes integrate upstream signals from nutrient and energy sensors, specifically mTORC1 and AMPK, to initiate the nucleation of the phagophore membrane (PMID: 25126726). In various diseases, including cancer and neurodegeneration, this machinery is often dysregulated, making it a high-priority therapeutic target (PMID: 30206156). Pharmacological strategies involve inhibiting these kinases to block autophagy-mediated survival in cancer or activating them to enhance the clearance of toxic aggregates in neurodegenerative conditions (PMID: 26118439). Current drug development focuses on small-molecule inhibitors of ULK1 and VPS34 to disrupt the early stages of autophagosome formation, though the dual role of autophagy in cell survival and death remains a significant therapeutic challenge.

Other names

ULK1 complexATG1 complexClass III PI3K complex IAutophagy-initiating protein complexPhagophore nucleation machinery

Inhibition or activation of the ULK1 and VPS34 kinase complexes to modulate the early stages of autophagosome formation and phagophore nucleation.